Annemette Samina Olesen Vøgg

Commercial Leader, Life Science, Strategy Developer, Business Execution, Global Scaling, Pharmaceuticals, MedTech

📍 Denmark🔄 Updated September 2026💼 1 investments📅 3 years investing🗓 Last invested Sep 2023
VC🌍 Denmark
1
Total investments
0
Early stage
1
Mid stage
0
Late stage
3y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Partner/ Investor
Sep 2023
CVX is building Scandinavias leading community of Business angels and facilitator of board positions. We invest in carefully selected start-ups and growth companies in collaboration with more than 700 active angel investors, board members, and entrepreneurs, and we have already helped around 100 companies grow by providing capital, knowledge, and networking.
Experience · 4 entries
All (4)
Investments (1)
2023
Venture Pilot
Oct 2023
Mind Your Own Business arbejder for, at alle drenge uanset baggrund får en fair chance i livet. Forskellighed bliver til en styrke, når vi i partnerskaber med dansk erhvervsliv, civilsamfund, boligforeninger og kommuner bruger iværksætteri som en platform for læring. Sammen styrker vi drengenes mulighed for et godt liv med fællesskab, job og uddannelse. Vi tror på, at alle mennesker har potentiale. Vi ved, at drengene har viljen.
Partner/ Investor
Sep 2023
CVX is building Scandinavias leading community of Business angels and facilitator of board positions. We invest in carefully selected start-ups and growth companies in collaboration with more than 700 active angel investors, board members, and entrepreneurs, and we have already helped around 100 companies grow by providing capital, knowledge, and networking.
2019
Global Brand Manager - Schizophrenia Portfolio (Abilify Maintena)
Sep 2019
Lundbeck is a biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, we are committed to improving the lives of people with neurological and psychiatric diseases. Brain disorders affect a large part of the world’s population, and the effects are felt throughout society. With the rapidly improving understanding of the biology of the brain, we hold ourselves accountable for advancing brain health by curiously exploring new opportunities for treatments. As a focused innovator, we strive for our research and development programs to tackle some of the most complex neurological challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology. We are committed to fighting stigma and we act to improve health equity. We strive to create long term value for our shareholders by making a positive contribution to patients, their families and society as a whole. Lundbeck has more than 5,000 employees in more than 20 countries and our products are available in more than 80 countries. For additional information, we encourage you to visit our corporate site www.lundbeck.com
2012
Unisense FertiliTech A/S
Business Unit Manager - Asia
Jul 2012